AU Patent

AU2015330670B2 — Therapeutic inhibition of lactate dehydrogenase and agents therefor

Assigned to Novo Nordisk Health Care AG · Expires 2022-01-06 · 4y expired

What this patent protects

This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels

USPTO Abstract

This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels

Drugs covered by this patent

Patent Metadata

Patent number
AU2015330670B2
Jurisdiction
AU
Classification
—
Expires
2022-01-06
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk Health Care AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.